nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—narcolepsy	0.807	1	CbGaD
Pseudoephedrine—SLC6A2—locus ceruleus—narcolepsy	0.0127	0.178	CbGeAlD
Pseudoephedrine—MAOA—locus ceruleus—narcolepsy	0.0117	0.164	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—narcolepsy	0.00672	0.0948	CbGeAlD
Pseudoephedrine—NFATC1—brain—narcolepsy	0.00334	0.047	CbGeAlD
Pseudoephedrine—IL2—brain—narcolepsy	0.00305	0.043	CbGeAlD
Pseudoephedrine—SLC6A3—brainstem—narcolepsy	0.00201	0.0284	CbGeAlD
Pseudoephedrine—SLC6A3—forebrain—narcolepsy	0.00194	0.0274	CbGeAlD
Pseudoephedrine—SLC6A4—brainstem—narcolepsy	0.00184	0.026	CbGeAlD
Pseudoephedrine—ADRB1—forebrain—narcolepsy	0.00184	0.026	CbGeAlD
Pseudoephedrine—SLC6A4—forebrain—narcolepsy	0.00178	0.0251	CbGeAlD
Pseudoephedrine—SLC6A2—brainstem—narcolepsy	0.00162	0.0229	CbGeAlD
Pseudoephedrine—SLC6A2—forebrain—narcolepsy	0.00157	0.0221	CbGeAlD
Pseudoephedrine—ADRA1A—brainstem—narcolepsy	0.00151	0.0213	CbGeAlD
Pseudoephedrine—MAOA—brainstem—narcolepsy	0.0015	0.0211	CbGeAlD
Pseudoephedrine—ADRA1A—forebrain—narcolepsy	0.00146	0.0205	CbGeAlD
Pseudoephedrine—MAOA—forebrain—narcolepsy	0.00144	0.0204	CbGeAlD
Pseudoephedrine—SLC6A3—midbrain—narcolepsy	0.00128	0.0181	CbGeAlD
Pseudoephedrine—SLC6A4—midbrain—narcolepsy	0.00118	0.0166	CbGeAlD
Pseudoephedrine—SLC6A2—medulla oblongata—narcolepsy	0.00113	0.016	CbGeAlD
Pseudoephedrine—ADRA2A—forebrain—narcolepsy	0.00111	0.0156	CbGeAlD
Pseudoephedrine—MAOA—medulla oblongata—narcolepsy	0.00104	0.0147	CbGeAlD
Pseudoephedrine—MAOA—midbrain—narcolepsy	0.000953	0.0134	CbGeAlD
Pseudoephedrine—CYP2D6—brainstem—narcolepsy	0.000889	0.0125	CbGeAlD
Pseudoephedrine—CYP2D6—forebrain—narcolepsy	0.000858	0.0121	CbGeAlD
Pseudoephedrine—SLC6A3—brain—narcolepsy	0.000806	0.0114	CbGeAlD
Pseudoephedrine—ADRA2A—medulla oblongata—narcolepsy	0.0008	0.0113	CbGeAlD
Pseudoephedrine—ADRB1—brain—narcolepsy	0.000765	0.0108	CbGeAlD
Pseudoephedrine—SLC6A4—brain—narcolepsy	0.000739	0.0104	CbGeAlD
Pseudoephedrine—ADRA2A—midbrain—narcolepsy	0.000731	0.0103	CbGeAlD
Pseudoephedrine—SLC6A2—brain—narcolepsy	0.00065	0.00917	CbGeAlD
Pseudoephedrine—ADRA1A—brain—narcolepsy	0.000605	0.00853	CbGeAlD
Pseudoephedrine—MAOA—brain—narcolepsy	0.000599	0.00845	CbGeAlD
Pseudoephedrine—ADRA2A—brain—narcolepsy	0.00046	0.00648	CbGeAlD
Pseudoephedrine—CYP2D6—brain—narcolepsy	0.000356	0.00502	CbGeAlD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.0003	0.00246	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Monoamine Transport—TNF—narcolepsy	0.000299	0.00246	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000296	0.00244	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000296	0.00244	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—HRH3—narcolepsy	0.000295	0.00242	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.000294	0.00241	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.000294	0.00241	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HCRTR1—narcolepsy	0.00029	0.00238	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HCRTR2—narcolepsy	0.00029	0.00238	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.00029	0.00238	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000289	0.00237	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000286	0.00235	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TNF—narcolepsy	0.000286	0.00235	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.000284	0.00233	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000282	0.00232	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.000282	0.00232	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HCRT—narcolepsy	0.000282	0.00231	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—P2RY11—narcolepsy	0.00028	0.0023	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—PENK—narcolepsy	0.000273	0.00224	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000268	0.0022	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRH3—narcolepsy	0.000268	0.0022	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000262	0.00215	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000257	0.00211	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000251	0.00206	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PENK—narcolepsy	0.000251	0.00206	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.000247	0.00203	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000246	0.00202	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000245	0.00202	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—TAC1—narcolepsy	0.000245	0.00201	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—NPS—narcolepsy	0.000245	0.00201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000243	0.002	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.000243	0.002	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.000243	0.002	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.000241	0.00198	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00024	0.00197	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HCRT—narcolepsy	0.000238	0.00196	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.000235	0.00193	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000234	0.00192	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.000226	0.00185	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.000226	0.00185	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TAC1—narcolepsy	0.000222	0.00182	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NPS—narcolepsy	0.000222	0.00182	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000222	0.00182	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00022	0.00181	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.000218	0.00179	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.000218	0.00179	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.000218	0.00179	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000217	0.00178	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000215	0.00177	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.000215	0.00177	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TRH—narcolepsy	0.000213	0.00175	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PENK—narcolepsy	0.000212	0.00174	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000211	0.00173	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00021	0.00173	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.000203	0.00167	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000203	0.00167	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.0002	0.00164	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000199	0.00163	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000195	0.0016	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000195	0.0016	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000189	0.00155	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRH3—narcolepsy	0.000187	0.00154	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.000187	0.00154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.000185	0.00152	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DQA1—narcolepsy	0.000185	0.00152	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000184	0.00152	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.000183	0.0015	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TRH—narcolepsy	0.000181	0.00148	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000178	0.00146	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000178	0.00146	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.000178	0.00146	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000174	0.00143	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000174	0.00143	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000174	0.00143	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DQB1—narcolepsy	0.000173	0.00142	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00017	0.00139	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00017	0.00139	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000166	0.00136	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000166	0.00136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.000165	0.00136	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.000164	0.00135	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.000164	0.00135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000162	0.00133	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00016	0.00132	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00016	0.00132	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRH3—narcolepsy	0.000158	0.0013	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DQA1—narcolepsy	0.000156	0.00128	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TAC1—narcolepsy	0.000155	0.00127	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NPS—narcolepsy	0.000155	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.000154	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.000154	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.000151	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.000151	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.000151	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.000149	0.00122	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—HTR2A—narcolepsy	0.000147	0.00121	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DQB1—narcolepsy	0.000146	0.0012	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.000146	0.0012	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000144	0.00119	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000144	0.00119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00014	0.00115	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.000139	0.00114	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CHKB—narcolepsy	0.000139	0.00114	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000137	0.00113	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000137	0.00113	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.000136	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.000136	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.000136	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000134	0.0011	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000134	0.0011	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HTR2A—narcolepsy	0.000134	0.0011	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.000133	0.00109	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.000133	0.00109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000133	0.00109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.000133	0.00109	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DRB1—narcolepsy	0.000131	0.00108	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NPS—narcolepsy	0.000131	0.00108	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TAC1—narcolepsy	0.000131	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.000131	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000128	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000128	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.000127	0.00104	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000125	0.00103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000125	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000125	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.000124	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.000124	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000123	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.000123	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000122	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.000121	0.000998	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00012	0.000989	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000117	0.000963	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000116	0.000952	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000116	0.000952	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.000113	0.000927	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.000113	0.000926	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.000112	0.000919	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DRB1—narcolepsy	0.000111	0.000912	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000111	0.000908	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00011	0.000906	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00011	0.000903	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00011	0.000903	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000107	0.000881	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.000106	0.000868	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000105	0.000862	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000105	0.000861	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.000103	0.000849	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.000102	0.000841	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000102	0.000839	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000102	0.000839	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000101	0.000832	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.0001	0.000826	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TRH—narcolepsy	9.59e-05	0.000788	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	9.51e-05	0.000782	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CPT1B—narcolepsy	9.46e-05	0.000777	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	9.41e-05	0.000773	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TRH—narcolepsy	9.38e-05	0.000771	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	9.34e-05	0.000767	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HTR2A—narcolepsy	9.33e-05	0.000767	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CHKB—narcolepsy	9.3e-05	0.000764	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	9.26e-05	0.000761	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PENK—narcolepsy	9.13e-05	0.00075	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	9.1e-05	0.000748	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	9.1e-05	0.000748	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—narcolepsy	9.06e-05	0.000744	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	9.06e-05	0.000744	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	8.9e-05	0.000732	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	8.9e-05	0.000732	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—P2RY11—narcolepsy	8.79e-05	0.000722	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	8.68e-05	0.000713	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—P2RY11—narcolepsy	8.6e-05	0.000707	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	8.54e-05	0.000702	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PENK—narcolepsy	8.48e-05	0.000697	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRH3—narcolepsy	8.41e-05	0.000691	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRH3—narcolepsy	8.23e-05	0.000676	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	8.17e-05	0.000671	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	8.06e-05	0.000663	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	7.99e-05	0.000656	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	7.94e-05	0.000652	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HTR2A—narcolepsy	7.89e-05	0.000648	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TRH—narcolepsy	7.76e-05	0.000638	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	7.67e-05	0.00063	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—NPS—narcolepsy	7.67e-05	0.00063	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	7.51e-05	0.000617	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—NPS—narcolepsy	7.51e-05	0.000617	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	7.49e-05	0.000616	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HCRT—narcolepsy	7.48e-05	0.000614	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	7.37e-05	0.000605	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	7.37e-05	0.000605	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HCRT—narcolepsy	7.31e-05	0.000601	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TRH—narcolepsy	7.21e-05	0.000592	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	7.11e-05	0.000584	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TAC1—narcolepsy	6.97e-05	0.000572	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NPS—narcolepsy	6.97e-05	0.000572	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	6.96e-05	0.000572	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	6.84e-05	0.000562	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	6.84e-05	0.000562	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TAC1—narcolepsy	6.82e-05	0.00056	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NPS—narcolepsy	6.82e-05	0.00056	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	6.8e-05	0.000559	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PENK—narcolepsy	6.66e-05	0.000547	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	6.61e-05	0.000543	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	6.61e-05	0.000543	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PENK—narcolepsy	6.52e-05	0.000535	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	6.32e-05	0.000519	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CPT1B—narcolepsy	6.32e-05	0.000519	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	6.21e-05	0.00051	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	6.21e-05	0.00051	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	6.14e-05	0.000505	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CHKB—narcolepsy	6.06e-05	0.000498	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HCRT—narcolepsy	6.05e-05	0.000497	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	5.77e-05	0.000474	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	5.77e-05	0.000474	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TRH—narcolepsy	5.67e-05	0.000465	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NPS—narcolepsy	5.64e-05	0.000463	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	5.64e-05	0.000463	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HCRT—narcolepsy	5.62e-05	0.000462	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TRH—narcolepsy	5.54e-05	0.000455	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PENK—narcolepsy	5.39e-05	0.000443	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NPS—narcolepsy	5.24e-05	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	5.24e-05	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PENK—narcolepsy	5.01e-05	0.000412	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRH3—narcolepsy	4.97e-05	0.000408	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRH3—narcolepsy	4.86e-05	0.000399	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	4.62e-05	0.000379	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TRH—narcolepsy	4.58e-05	0.000377	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	4.52e-05	0.000371	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TRH—narcolepsy	4.26e-05	0.00035	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	4.19e-05	0.000344	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CPT1B—narcolepsy	4.12e-05	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TAC1—narcolepsy	4.12e-05	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NPS—narcolepsy	4.12e-05	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	4.1e-05	0.000337	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NPS—narcolepsy	4.03e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TAC1—narcolepsy	4.03e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRH3—narcolepsy	4.02e-05	0.00033	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	3.73e-05	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRH3—narcolepsy	3.73e-05	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	3.47e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	3.39e-05	0.000279	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NPS—narcolepsy	3.33e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TAC1—narcolepsy	3.33e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	3.15e-05	0.000259	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NPS—narcolepsy	3.09e-05	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TAC1—narcolepsy	3.09e-05	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—narcolepsy	2.48e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—narcolepsy	2.42e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	2e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	1.86e-05	0.000153	CbGpPWpGaD
